Clinical Trial Update: Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on glucomannan in children with non-alcoholic fatty liver disease, including metabolic syndrome and insulin resistance considerati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome
• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Glucomannan (glucomannan)

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: Metabolic Syndrome, Non Alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED